Indivior News | finanzen.ch

Indivior Aktie VALOR 26391547 / ISIN US45579E1055

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Trading-Depot

Aktion

Portfolio

Watchlist

12.02.19	Indivior loses U.S. district court battle, copycat launches imminent (Reuters)
25.01.19	Indivior temporarily stops rival Alvogen's generic launch (Reuters)
18.12.18	Indivior plans cheaper opioid addiction drug if rivals launch copycats (Reuters)
18.12.18	Indivior plans cheaper opioid addiction drug to keep copycats at bay (Reuters)
18.12.18	Indivior to launch cheaper opioid addiction drug; maintains forecast (Reuters)
12.12.18	Indivior wins fresh hold on Dr. Reddy's Suboxone copy (Reuters)
12.12.18	Indivior says wins fresh hold on Suboxone copy (Reuters)
21.11.18	Indivior backs FY view, warns of generic rival hit; shares fall (Reuters)
21.11.18	Indivior sticks to FY outlook, warns of hit from generic rival (Reuters)
20.11.18	U.S. court allows generic version of Indivior opioid abuse drug (Reuters)
01.11.18	Cost cuts help drugmaker Indivior as it battles cheap rival (Reuters)
01.11.18	Indivior quarterly profit rises, on track to meet FY revenue targets (Reuters)
12.09.18	Teva to hold Indivior generic drug launch pending U.S. ruling (Reuters)
31.07.18	Indivior: U.S. court rules against generic rival's appeal (Reuters)
31.07.18	Indivior says U.S. court rules against generic rival's appeal (Reuters)
30.07.18	U.S. court expedites Indivior rival Dr. Reddy's appeal to re-launch generic drug (Reuters)
25.07.18	Indivior warns of bigger hit from copycat drug (Reuters)
14.07.18	Indivior wins preliminary injunction against generic rival (Reuters)
11.07.18	Indivior says 2018 profit to fall short after U.S. market hit (Reuters)
11.07.18	Indivior says 2018 revenue, net income to come in below expectations (Reuters)
01.09.17	London-listed drugmaker Indivior shares crash after U.S. patent blow (Reuters)

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Novartis	99.27	0.39 %	K V
UBS Group	30.73	0.16 %	K V
Alcon	59.80	0.10 %	K V
Sika	157.20	0.06 %	K V
Holcim	71.34	0.03 %	K V
Roche Hldg G	258.90	-1.07 %	K V
CieFinRichemont	158.70	-1.18 %	K V
Zurich Insur Gr	559.00	-1.72 %	K V
Swiss Re	146.60	-1.91 %	K V